Pharmaceutical API Supplier for Canada — WHO-GMP Export from India

Aarise Pharma is a WHO-GMP certified pharmaceutical API manufacturer and exporter based in Haridwar, India, supplying bulk active pharmaceutical ingredients and third-party manufactured dispersible tablet formulations to buyers in Canada. Every shipment ships with an independent Certificate of Analysis (COA) and full regulatory documentation.

Pharmaceutical API Supplier for Canada — Why Buyers Choose India

Health Canada regulates API imports through its Drug Establishment Licence (DEL) framework. A Certificate of Suitability or equivalent Drug Master File documentation supports Notice of Compliance (NOC) filings for finished drug products using the imported API. Aarise Pharma works directly with pharmaceutical manufacturers, contract formulators, and distributors in Canada sourcing bulk APIs from India as an addition to, or replacement for, existing suppliers.

API & Formulation Categories Available for Canada

Active Pharmaceutical Ingredients (APIs)

Bulk APIs across therapeutic categories including analgesics, antibiotics, antihistamines, and gastrointestinal formulations, manufactured to USP/BP/EP pharmacopoeial standards.

Dispersible Tablet Formulations

Contract-manufactured dispersible tablets, formulated and packaged to your specification — a core capability of the Haridwar facility.

Third-Party Manufacturing

Full third-party manufacturing for finished dosage forms, from formulation through packaging, for buyers in Canada looking to private-label or scale an existing product line.

Quality Documentation We Provide

Every order from Aarise Pharma includes a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and WHO-GMP compliance documentation. Buyers requiring DMF (Drug Master File) reference can request current copies alongside standard COA/MSDS documentation.

Shipping to Canada

Standard delivery to Canada is 10-16 business days by air freight, 28-35 days by sea. We handle export documentation and coordinate with your customs broker or local registration holder where the import process requires one.

Regulatory Information for Canada

Health Canada is the national authority governing pharmaceutical imports into Canada. Health Canada regulates API imports through its Drug Establishment Licence (DEL) framework. A Certificate of Suitability or equivalent Drug Master File documentation supports Notice of Compliance (NOC) filings for finished drug products using the imported API.

Frequently Asked Questions

What pharmaceutical APIs does Aarise Pharma supply to Canada?

Aarise Pharma manufactures and exports WHO-GMP certified active pharmaceutical ingredients, dispersible tablet formulations, and third-party manufactured finished products for buyers in Canada, including generic drug manufacturers, contract formulators, and pharmaceutical distributors.

What documentation do you provide for Health Canada compliance?

Every shipment includes a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and DMF (Drug Master File) reference, formatted to support your Health Canada registration or import filing.

How long does shipping to Canada take?

Standard delivery to Canada is 10-16 business days by air freight, 28-35 days by sea. We coordinate directly with your customs broker or local registration holder where the import process requires one.

Can Aarise Pharma manufacture a custom formulation for us?

Yes. Beyond bulk APIs, Aarise Pharma offers third-party contract manufacturing for dispersible tablets and other finished dosage forms, built to your specification and packaging requirements.

How do we request a quotation?

Send your required molecule, quantity, and target specification through our contact form, and our export team will respond with pricing, MOQ, and lead time within one business day.

Get Started — Request a Quotation for Canada

Send us your required molecule, quantity, and specification, and our export team will respond with pricing, minimum order quantity, and lead time within one business day.